The First DNA-Powered
Pet Supplement Protocol
GenePaws.AI is building the precision pet health platform — combining genomics, AI, and proprietary formulations to create the only supplement protocol that's truly personalized to your pet's DNA.
THE OPPORTUNITY
Market Size & Traction
Global Pet Market
2025, growing 6.1% CAGR
Pet Supplement Market
2025, growing 8.4% CAGR
Pet DNA Testing Market
2025, growing 15.2% CAGR
Proprietary SKUs
DNA-triggered, trade secret
REVENUE MODEL
Three Compounding Revenue Streams
$89.99
DNA Kit — One-Time
Per-kit revenue with high margin. Each kit unlocks the dashboard and creates a lifetime customer relationship.
$49–$89/mo
Supplement Subscription
Monthly recurring revenue from auto-refill supplement protocols. DNA-matched formulas drive retention — customers stay because the protocol is personalized.
Custom
B2B & Vet Partnerships
Wholesale pricing for veterinary clinics, pet retailers, and creator affiliates. White-glove onboarding for vet practices.
COMPETITIVE MOAT
Why GenePaws.AI Wins
Proprietary Formula Library
35 DNA-triggered SKUs protected as trade secrets under the Defend Trade Secrets Act. NDA required before sharing with any co-manufacturer. No competitor can replicate our exact formulations.
AI Model v2.4 — Proprietary
Our AI analyzes 247+ genetic markers in ~4 seconds. Trained on 10,000+ peer-reviewed studies. The model is continuously updated as new veterinary science emerges.
Multi-Species DNA Panel
Dogs (247+ markers), Cats (68+), Horses (180+), Birds (40+), Reptiles (35+), Fish (30+), Poultry, Small Mammals. No competitor covers 8 species with DNA-matched supplements.
Vet-Supervised Protocol
Every AI-generated protocol is reviewed by a board-certified veterinary nutritionist (DACVN) before delivery. This creates a regulatory and trust moat competitors cannot easily replicate.
Data Network Effects
Every DNA kit processed improves our AI model. As we scale, our genetic database becomes the most comprehensive pet genomics dataset in the world — creating a data moat.
Vertical Integration Path
Currently manufacturing in India (bulk) + USA (bottling). Roadmap includes acquiring a CMO to fully vertically integrate and capture manufacturing margin.
PRODUCT ROADMAP
$1M Bootstrap → Series A
LEADERSHIP
Built by Experts
CEO & Co-Founder
Veterinary Genomics Expert
15+ years in veterinary genomics and precision medicine
CTO & Co-Founder
AI/ML Engineer
Former senior ML engineer at a leading genomics company
Chief Veterinary Officer
Dr. Sarah Chen, DVM, DACVN
Board-certified veterinary nutritionist, 12+ years clinical experience
Ready to Learn More?
Request our full investor deck, financial model, and due diligence package. NDA available upon request.